SHWZ (Medicine Man Technologies) Research & Development: $0.0 Mil (TTM As of Jun. 2024)


SHWZ Medicine Man Technologies Inc SHWZ
12 GF Score
Price $0.00
View Full Analysis

What is Medicine Man Technologies Research & Development?

Medicine Man Technologies SHWZ -90.00% 12 Research & Development is $0.0 Mil as of Jun. 2024. GuruFocus rates SHWZ with a GF Score™ of 12/100.

Research & Development is the aggregate amount of research and development expenses during the year. Medicine Man Technologies's Research & Development for the three months ended in Jun. 2024 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was $0.0 Mil.

Medicine Man Technologies  (OTCPK:SHWZ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medicine Man Technologies Research & Development Related Terms

Medicine Man Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Medicine Man Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicine Man Technologies Research & Development Chart

Medicine Man Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medicine Man Technologies Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHWZ
12GF Score
Medicine Man Technologies Inc SHWZ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicine Man Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Medicine Man Technologies (SHWZ) has a Research & Development of $0.0 Mil as of Jun. 2024. Research and development expense is the total cost for research and development activities. View historical data on Medicine Man Technologies and its competitors.
Is Medicine Man Technologies' Research & Development too high?
Medicine Man Technologies' current Research & Development is $0.0 Mil. Overall, Medicine Man Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medicine Man Technologies' Research & Development compare to HEWA and RDGT?
Medicine Man Technologies' Research & Development of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Medicine Man Technologies and its competitors. Medicine Man Technologies's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicine Man Technologies stock overvalued right now?
Medicine Man Technologies (SHWZ) has a current Research & Development of $0.0 Mil. The current Research & Development is $0.0 Mil. Medicine Man Technologies' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Medicine Man Technologies (SHWZ), the current Research & Development is $0.0 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicine Man Technologies Business Description

Address 865 N. Albion Street, Suite 300, Denver, CO, USA, 80220
Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company's business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.
12GF Score

Get the complete analysis for SHWZ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price